We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$17.9B
AUM Growth
-$597M
(-3.2%)
Cap. Flow
-$1.32B
Cap. Flow
% of AUM
-7.36%
Top 10 Holdings %
Top 10 Hldgs %
8.81%
Holding
1,709
New
345
Increased
450
Reduced
603
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$146M |
| 2 |
Apple
AAPL
|
+$129M |
| 3 |
Tesla
TSLA
|
+$110M |
| 4 |
Medtronic
MDT
|
+$104M |
| 5 |
Verizon
VZ
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$181M |
| 2 |
Microsoft
MSFT
|
+$177M |
| 3 |
Comcast
CMCSA
|
+$173M |
| 4 |
Adobe
ADBE
|
+$163M |
| 5 |
Broadcom
AVGO
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 14.31% |
| 3 | Consumer Discretionary | 12.9% |
| 4 | Industrials | 11.52% |
| 5 | Financials | 10.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Expro Ltd
XPRO
$2.07B
| $921K | 0.01% |
+50,826
| New | +$862K |
|
1152
Alcoa
AA
$13.5B
| $920K | 0.01% |
20,226
-45,207
| -69% | -$1.97M |
|
1153
Melco Resorts & Entertainment
MLCO
$2.14B
| $908K | 0.01% |
78,930
-411,574
| -84% | -$3.34M |
|
1154
Aptiv
APTV
$10.1B
| $907K | 0.01% |
9,744
-328,330
| -97% | -$31.2M |
|
1155
Urban Outfitters
URBN
$6.63B
| $907K | 0.01% |
38,016
-496,216
| -93% | -$12.4M |
|
1156
MakeMyTrip
MMYT
$5.67B
| $905K | 0.01% |
32,818
-16,620
| -34% | -$480K |
|
1157
St. Joe Company
JOE
$3.87B
| $899K | 0.01% |
23,254
+2,289
| +11% | +$82K |
|
1158
MYR Group
MYRG
$5.18B
| $898K | 0.01% |
+9,750
| New | +$885K |
|
1159
Rapid7
RPD
$827M
| $895K | 0.01% |
26,336
-13,795
| -34% | -$493K |
|
1160
Northwest Bancshares
NWBI
$2.3B
| $883K | ﹤0.01% |
63,182
-136,642
| -68% | -$1.97M |
|
1161
The Ensign Group
ENSG
$10.6B
| $883K | ﹤0.01% |
9,334
-45,273
| -83% | -$4.11M |
|
1162
Johnson Controls International
JCI
$92.6B
| $883K | ﹤0.01% |
13,793
-577,923
| -98% | -$35.4M |
|
1163
ArcBest
ARCB
$3.14B
| $883K | ﹤0.01% |
+12,603
| New | +$973K |
|
1164
Intel
INTC
$509B
| $871K | ﹤0.01% |
32,942
-913,961
| -97% | -$25.4M |
|
1165
RenaissanceRe
RNR
$13.2B
| $861K | ﹤0.01% |
+4,672
| New | +$787K |
|
1166
ScottsMiracle-Gro
SMG
$3.62B
| $861K | ﹤0.01% |
+17,712
| New | +$887K |
|
1167
Citi Trends
CTRN
$617M
| $858K | ﹤0.01% |
32,407
-67,756
| -68% | -$1.59M |
|
1168
Universal Display
OLED
$4.23B
| $854K | ﹤0.01% |
7,909
-76,187
| -91% | -$7.99M |
|
1169
Invesco Mortgage Capital
IVR
$802M
| $845K | ﹤0.01% |
+66,346
| New | +$811K |
|
1170
Ligand Pharmaceuticals
LGND
$5.85B
| $844K | ﹤0.01% |
+12,628
| New | +$821K |
|
|
SAND
1171
DELISTED
Sandstorm Gold
SAND
| $840K | ﹤0.01% |
+159,744
| New | +$816K |
|
|
MOMO
1172
Hello Group
MOMO
$867M
| $828K | ﹤0.01% |
+92,215
| New | +$547K |
|
1173
Moody's
MCO
$82.8B
| $828K | ﹤0.01% |
2,970
-1,923
| -39% | -$526K |
|
1174
Performance Food Group
PFGC
$16.9B
| $823K | ﹤0.01% |
14,103
+8,985
| +176% | +$490K |
|
|
GTHX
1175
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $820K | ﹤0.01% |
150,930
-177,870
| -54% | -$1.49M |
|
Similar funds
VAI
Voloridge Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, Voloridge Investment Management held 1,709 positions worth $17.9B, down 3.2% from $18.5B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Voloridge Investment Management withdrew a net $1.32B in Q4 2022, closing 311 positions and reducing 603 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $181M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in Edwards Lifesciences worth $142M.
- Voloridge Investment Management's largest Q4 2022 buy was Edwards Lifesciences: 1,898,822 shares worth $142M.
- Voloridge Investment Management added most to Tesla in Q4 2022, an estimated $110M increase.
- Voloridge Investment Management's biggest Q4 2022 reduction was Microsoft, cutting an estimated $177M.
- Voloridge Investment Management fully exited Berkshire Hathaway Class B in Q4 2022, selling an estimated $181M.
- Voloridge Investment Management's ten largest holdings make up 8.8% of its $17.9B portfolio in Q4 2022.
- Voloridge Investment Management opened 345 new positions and closed 311 in Q4 2022.
- Voloridge Investment Management's portfolio value fell 3.2% quarter-over-quarter to $17.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.